What makes a sound investment in global health?
In this video interview, Devex Editor Rolf Rosenkranz asked Anastasia Thatcher, head of global health at Accenture Development Partnerships, who discussed how firms can figure out the right market to enter so they can deliver both the business and development outcomes they are aiming for, and gave the example of a Novartis-led program to make affordable pharmaceutical drugs for poor customers in India as an example of a “best buy” in her line of work.
Thatcher also discussed recent trends in the sector, mainly strengthening local health systems, making technology more available to the “base of the pyramid” and innovative financing.
Click on the above clips to learn more insights from the chief of global health at Accenture, an international management consulting, technology services and outsourcing company that is rapidly increasing its development footprint on a global scale.
This story is part of Best Buys in Global Health, a campaign by PSI, PATH and Devex to highlight sound investments in global health. Find out more.
About the author
Carlos Santamaria
Carlos is a former associate editor for breaking news in Devex's Manila-based news team. He joined Devex after a decade working for international wire services Reuters, AP, Xinhua, EFE ,and Philippine social news network Rappler in Madrid, Beijing, Manila, New York, and Bangkok. During that time, he also covered natural disasters on the ground in Myanmar and Japan.
